Sanitec CEO Peter Nilsson said, “Over the last four years, we relentlessly worked on consolidating and improving our operations and maintaining our leading position in our core markets in Europe. We are very proud of our business, the attractiveness of our European footprint and of our improved financial performance. We firmly believe that we are well positioned to further leverage the strength of our platform and to take advantage of the European macro recovery”.
Caspar Callerström, partner at EQT Partners, added, “We are very excited about broadening the investor base for Sanitec and we see the IPO as an important new phase for the company which will allow Sanitec to further enhance its public markets profile also following the successful high yield bond issuance earlier this year. We look forward to continuing to support the business and welcome new shareholders in Sanitec and offer them the opportunity to be part of our development going forward”.
Nordea and UBS Investment Bank are acting as joint global coordinators and joint bookrunners. Carnegie is acting as joint bookrunner and Handelsbanken is acting as co-lead manager.
Sanitec recorded sales of €753m in 2012 with EBITDA of €103m. The company has operations in 19 countries with 11 production facilities and approximately 6,500 employees. In 2012, 25 per cent of its net sales were generated in North Europe, 29 per cent in Central Europe, seven per cent in the UK and Ireland, 19 per cent in South Europe, 17 per cent in East Europe , and thee per cent in the Rest of the World.
Back in 2011, it was reported that EQT was looking to sell the company for as much as €1bn and hired UBS to advise it on the process.
Copyright © 2013 AltAssets